ET140203 T cells

· Eureka Therapeutics Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ET140203 T cells, covering 2025-04-09 to 2025-09-08. Get the full timeline:

Most recent: Clinical Trial Update: Study of ET140203 T Cells in Adults With Advanced Hepatocellular Carcinoma (ARYA-1) [Phase 1]